BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 19275503)

  • 1. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
    Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
    PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases.
    Shekhanawar M; Shekhanawar SM; Krisnaswamy D; Indumati V; Satishkumar D; Vijay V; Rajeshwari T; Amareshwar M
    J Clin Diagn Res; 2013 Jul; 7(7):1284-7. PubMed ID: 23998046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pitavastatin treatment on PON1 lactonase activity in patients with hypercholesterolaemia.
    Kotani K; Sakane N; Gugliucci A
    Arch Med Sci Atheroscler Dis; 2024; 9():e16-e17. PubMed ID: 38434942
    [No Abstract]   [Full Text] [Related]  

  • 4. A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.
    Petrič B; Kunej T; Bavec A
    OMICS; 2021 Jan; 25(1):38-51. PubMed ID: 33306925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Anthocyanins and Their Microbial Metabolites on the Expression and Enzyme Activities of Paraoxonase 1, an Important Marker of HDL Function.
    Aboufarrag HT; Needs PW; Rimbach G; Kroon PA
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.
    Cervellati C; Valacchi G; Tisato V; Zuliani G; Marsillach J
    Minerva Med; 2019 Jun; 110(3):238-250. PubMed ID: 30334443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactonase Activity and Lipoprotein-Phospholipase A
    Hayek J; Cervellati C; Crivellari I; Pecorelli A; Valacchi G
    Oxid Med Cell Longev; 2017; 2017():5694058. PubMed ID: 29317982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.
    Eren E; Abuhandan M; Solmaz A; Taşkın A
    J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):163-8. PubMed ID: 25241610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase-1 status in patients with hereditary hemochromatosis.
    Martinelli N; García-Heredia A; Roca H; Aranda N; Arija V; Mackness B; Mackness M; Busti F; Aragonès G; Pedro-Botet J; Pedica F; Cataldo I; Marsillach J; Joven J; Girelli D; Camps J
    J Lipid Res; 2013 May; 54(5):1484-92. PubMed ID: 23471031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 in chronic kidney failure.
    Gugliucci A; Kotani K; Kimura S
    J Lipids; 2012; 2012():726048. PubMed ID: 22523692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.
    Martinelli N; Micaglio R; Consoli L; Guarini P; Grison E; Pizzolo F; Friso S; Trabetti E; Pignatti PF; Corrocher R; Olivieri O; Girelli D
    Exp Diabetes Res; 2012; 2012():231502. PubMed ID: 21960992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel serum paraoxonase activity assays are associated with coronary artery disease.
    Martinelli N; Girelli D; Olivieri O; Guarini P; Bassi A; Trabetti E; Friso S; Pizzolo F; Bozzini C; Tenuti I; Annarumma L; Schiavon R; Franco Pignatti P; Corrocher R
    Clin Chem Lab Med; 2009; 47(4):432-40. PubMed ID: 19275503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
    Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Guan LB; Fan P
    J Diabetes Res; 2020; 2020():3483427. PubMed ID: 32090118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
    Zhang Y; Liu H; He J; Xu K; Bai H; Wang Y; Zhang F; Zhang J; Cheng L; Fan P
    Eur J Endocrinol; 2015 Apr; 172(4):391-402. PubMed ID: 25575948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes of oxidative stress and PON1 lactonase activity and status in older pregnant women undergoing assisted reproductive technology: a prospective nested case-control study.
    Jiang C; Chen M; Wu Y; Bai H; Liu X; Fan P
    Reprod Biol Endocrinol; 2023 Oct; 21(1):97. PubMed ID: 37885002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in paraoxonase-1 activity and atherosclerosis.
    Soran H; Younis NN; Charlton-Menys V; Durrington P
    Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonases: structure, gene polymorphism & role in coronary artery disease.
    Gupta N; Gill K; Singh S
    Indian J Med Res; 2009 Oct; 130(4):361-8. PubMed ID: 19942738
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.